Newer CHCs linked to higher risk of VTE, says FDA report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1376, 2011-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral estrogen linked with increased VTE risk

By  

Reactions Weekly, Vol. 1, Iss. 1148, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

The risk of fatal venous thromboembolism (VTE) may be higher with desogestrel- than with levonorgestrel-

By  

Inpharma, Vol. 1, Iss. 1510, 2005-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Conventional antipsychotic use linked to VTE

By  

Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Risk of VTE with Ortho Evra?

By  

Reactions Weekly, Vol. 1, Iss. 1092, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Ximelagatran reduces risk of VTE

By  

Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite